Broadwood partners comments on staar surgical's late and troubling disclosure in deeply flawed sale process to alcon

New york--(business wire)--broadwood partners, l.p. and its affiliates (“broadwood” or “we”) today commented on the recent current report on form 8-k filed by staar surgical company (“staar” or the “company”) (nasdaq: staa) with the u.s. securities and exchange commission (“sec”) of a “supplement” to the company's definitive proxy statement, filed on september 16, 2025, in connection with the proposed acquisition of staar by alcon inc. (“alcon”) (nyse: alc). broadwood, which owns 27.5% of staar.
ALC Ratings Summary
ALC Quant Ranking